Stock listing
NASDAQ:SGMT Sagimet Biosciences Inc. - Series A Stock
Home listing (NASDAQ) of Sagimet Biosciences Inc. - Series A
Follow Sagimet Biosciences Inc. - Series A into a list and get an email when it puts out news.
Share price · NASDAQ:SGMT
$8.86 USD +0.84 (+10.5%)
Close on Oct 19, 2026
- Day range
- $8.18 – $9.01 USDOct 19, 2026
- Volume
- 1.68M sharesOct 19, 2026
- Market cap
- $628.3M USDAt the close on Oct 19, 2026 · price × 70.91M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SGMT · Home | $8.86 USD | +0.84 (+10.5%) | 1,684,035 | $8.195 | $9.005 | $8.175 | $8.02 | Close on Oct 19, 2026 |
| Frankfurt:0O2 | €7.00 EUR | -0.06 (-0.8%) | — | €7.06 | €7.06 | €7.00 | €7.06 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:SGMT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.86 | +0.84 | +10.5% | $8.195 | $9.005 | $8.175 | 1,684,035 | |
| $8.02 | -0.15 | -1.8% | $8.15 | $8.25 | $7.94 | 1,088,857 | |
| $8.17 | +0.625 | +8.3% | $7.61 | $8.275 | $7.54 | 1,366,994 | |
| $7.545 | -0.435 | -5.5% | $7.78 | $8.00 | $7.51 | 1,983,319 | |
| $7.98 | -0.82 | -9.3% | $8.70 | $8.74 | $7.88 | 2,349,186 | |
| $8.80 | -0.13 | -1.5% | $8.85 | $9.145 | $8.735 | 1,157,408 | |
| $8.93 | +0.01 | +0.1% | $8.84 | $9.05 | $8.78 | 763,531 | |
| $8.92 | +0.04 | +0.5% | $8.80 | $8.94 | $8.63 | 1,229,349 | |
| $8.88 | +0.12 | +1.4% | $8.65 | $8.97 | $8.598 | 631,600 | |
| $8.76 | -0.27 | -3.0% | $8.99 | $8.99 | $8.55 | 896,300 | |
| $9.03 | -0.11 | -1.2% | $9.075 | $9.12 | $8.40 | 1,528,700 | |
| $9.14 | -0.23 | -2.5% | $9.26 | $9.38 | $8.88 | 1,712,500 | |
| $9.37 | -0.51 | -5.2% | $9.63 | $10.01 | $9.315 | 2,008,400 | |
| $9.88 | +0.55 | +5.9% | $10.61 | $10.93 | $9.46 | 5,453,100 | |
| $9.33 | -0.61 | -6.1% | $9.92 | $9.92 | $9.25 | 856,800 | |
| $9.94 | +0.70 | +7.6% | $9.15 | $9.95 | $9.025 | 1,345,800 | |
| $9.24 | +0.13 | +1.4% | $9.11 | $9.265 | $8.89 | 1,246,500 | |
| $9.11 | -1.31 | -12.6% | $9.78 | $9.99 | $8.685 | 3,722,700 | |
| $10.42 | -0.67 | -6.0% | $11.23 | $11.26 | $10.15 | 1,115,900 | |
| $11.09 | +0.29 | +2.7% | $10.84 | $11.33 | $10.72 | 874,100 | |
| $10.80 | -0.29 | -2.6% | $11.20 | $11.21 | $10.66 | 753,300 | |
| $11.09 | -0.08 | -0.7% | $11.17 | $11.40 | $10.80 | 1,854,000 | |
| $11.17 | +0.71 | +6.8% | $10.69 | $11.34 | $10.68 | 1,019,100 | |
| $10.46 | 0.00 | 0.0% | $10.51 | $10.62 | $10.25 | 620,600 | |
| $10.46 | -0.42 | -3.9% | $10.81 | $10.84 | $10.31 | 852,700 | |
| $10.88 | 0.00 | 0.0% | $10.96 | $11.10 | $10.82 | 516,700 | |
| $10.88 | -0.18 | -1.6% | $11.33 | $11.35 | $10.77 | 639,400 | |
| $11.06 | +0.20 | +1.8% | $10.75 | $11.45 | $10.67 | 937,700 | |
| $10.86 | +0.15 | +1.4% | $11.25 | $11.27 | $10.69 | 1,249,900 | |
| $10.71 | -0.23 | -2.1% | $10.84 | $11.17 | $10.65 | 805,400 | |
| $10.94 | +0.02 | +0.2% | $10.79 | $10.98 | $10.53 | 1,250,100 | |
| $10.92 | -0.07 | -0.6% | $11.21 | $11.24 | $10.62 | 1,142,100 | |
| $10.99 | +0.49 | +4.7% | $10.51 | $11.06 | $10.51 | 1,798,000 | |
| $10.50 | +0.24 | +2.3% | $10.15 | $10.72 | $10.15 | 752,200 | |
| $10.26 | -0.29 | -2.7% | $10.36 | $10.44 | $10.21 | 688,400 | |
| $10.55 | -0.20 | -1.9% | $10.62 | $10.81 | $10.47 | 574,000 | |
| $10.75 | -0.11 | -1.0% | $10.90 | $10.95 | $10.54 | 657,600 | |
| $10.86 | +0.57 | +5.5% | $10.26 | $10.87 | $10.11 | 1,236,700 | |
| $10.29 | +0.08 | +0.8% | $10.38 | $10.60 | $10.20 | 968,555 | |
| $10.21 | -0.04 | -0.4% | $10.13 | $10.51 | $9.95 | 1,242,184 | |
| $10.25 | +0.07 | +0.7% | $10.22 | $10.48 | $10.06 | 1,022,300 | |
| $10.18 | -0.40 | -3.8% | $10.48 | $10.64 | $10.15 | 1,138,700 | |
| $10.58 | 0.00 | 0.0% | $10.80 | $11.03 | $10.49 | 1,552,000 | |
| $10.58 | +0.15 | +1.4% | $10.41 | $10.74 | $10.38 | 980,500 | |
| $10.43 | -0.12 | -1.1% | $10.45 | $11.15 | $10.28 | 1,810,900 | |
| $10.55 | +1.27 | +13.7% | $9.42 | $10.60 | $9.07 | 2,659,500 | |
| $9.28 | -0.11 | -1.2% | $9.52 | $9.67 | $9.15 | 966,000 | |
| $9.39 | -0.13 | -1.4% | $9.55 | $9.85 | $9.38 | 1,096,100 | |
| $9.52 | -0.05 | -0.5% | $9.57 | $10.01 | $9.28 | 1,480,400 | |
| $9.57 | +0.51 | +5.6% | $8.91 | $9.61 | $8.80 | 1,799,200 | |
| $9.06 | +0.32 | +3.7% | $8.91 | $9.09 | $8.45 | 1,113,100 | |
| $8.74 | +0.10 | +1.2% | $8.46 | $8.975 | $8.29 | 1,465,300 | |
| $8.64 | +0.65 | +8.1% | $8.00 | $8.74 | $7.96 | 2,137,200 | |
| $7.99 | +0.84 | +11.7% | $7.15 | $8.00 | $7.15 | 1,706,000 | |
| $7.15 | +0.04 | +0.6% | $6.74 | $7.20 | $6.50 | 2,990,800 | |
| $7.11 | -0.20 | -2.7% | $7.32 | $7.33 | $6.88 | 616,100 | |
| $7.31 | +0.27 | +3.8% | $7.07 | $7.35 | $7.00 | 389,900 | |
| $7.04 | -0.23 | -3.2% | $7.25 | $7.39 | $7.01 | 465,000 | |
| $7.27 | -0.18 | -2.4% | $7.40 | $7.48 | $7.13 | 392,600 | |
| $7.45 | +0.38 | +5.4% | $7.12 | $7.59 | $7.025 | 544,000 | |
| $7.07 | +0.06 | +0.9% | $7.14 | $7.20 | $6.86 | 910,900 | |
| $7.01 | -0.04 | -0.6% | $7.025 | $7.08 | $6.87 | 619,400 | |
| $7.05 | -0.02 | -0.3% | $7.10 | $7.245 | $7.00 | 780,500 | |
| $7.07 | -0.09 | -1.3% | $7.06 | $7.22 | $7.00 | 758,700 | |
| $7.16 | -0.66 | -8.4% | $7.76 | $8.02 | $7.15 | 943,000 |
- Ticker
- NASDAQ:SGMT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 9, 2026
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference
Latest deck · September 2026
Sagimet Biosciences — Investor Presentation (September 2026)
Investor deck · 30 slides
Latest news
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference
Oct 9, 2026
Closed $8.93 (+0.1%) on Oct 9, 2026
Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
Oct 1, 2026
Closed $9.14 (-2.5%) on Oct 2, 2026
Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
Sep 30, 2026
Closed $9.88 (+5.9%) on Sep 30, 2026
Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026
Sep 30, 2026
Closed $9.88 (+5.9%) on Sep 30, 2026
Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026
Sep 28, 2026
Closed $9.94 (+7.6%) on Sep 28, 2026
Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026
Aug 25, 2026
Closed $10.29 (+0.8%) on Aug 25, 2026
Sagimet Biosciences Announces Inducement Grant under Nasdaq Listing Rule 5635(4)
Aug 18, 2026
Closed $10.58 (+1.4%) on Aug 18, 2026
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 17, 2026
Closed $10.58 (+1.4%) on Aug 18, 2026
Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients
Aug 13, 2026
Closed $9.28 (-1.2%) on Aug 13, 2026
Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Aug 11, 2026
Closed $9.52 (-0.5%) on Aug 11, 2026
Decks
Sagimet Biosciences — Investor Presentation (September 2026)
Investor deck · 30 slides · September 2026
Sagimet Biosciences — Corporate Update (August 2026)
Corporate update · 22 slides · Aug 11, 2026
Sagimet Biosciences — Investor Presentation (July 2026)
Investor deck · 22 slides · Jul 21, 2026
Sagimet Biosciences — Corporate Update (April 2026)
Corporate update · 22 slides · Apr 30, 2026
Sagimet Biosciences Inc. - Series A on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 88 in all · newest Oct 9, 2026 · oldest 2023
- Decks
- 32 decks · latest September 2026
Where Sagimet Biosciences Inc. - Series A is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SGMT · Home listing · This page | NASDAQ | United States | USD |
| gettex:0O2 | gettex | Germany | EUR |
| BOATS:SGMT | BOATS | United States | USD |
| Lang & Schwarz:A3CPAM | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3CPAM | LS Exchange | Germany | EUR |
| Munich:0O2 | Munich | Germany | EUR |
| Dusseldorf:0O2 | Dusseldorf | Germany | EUR |
| Tradegate:0O2 | Tradegate | Germany | EUR |
| Frankfurt:0O2 | Frankfurt | Germany | EUR |
| Stuttgart:0O2 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Sagimet Biosciences Inc. - Series A.